10-Color Panel Design on the
BD FACSCanto™ System

BD Biosciences
Stay Informed Schedule a Meeting

About This Event

Quality flow cytometry data starts with proper panel design. Fluorochrome choices, instrument configurations/setup and knowledge of the biology being studied are important factors when considering panel choices. This webinar will provide you with a foundation to easily build the best possible panels to answer your experimental questions by using the 10-color capability of the BD FACSCanto™ flow cytometer. The foundational introduction will be followed by an overview of user defined panels, demonstrating how to maximize resolution of cell populations when running the BD FACSCanto system. This overview will include the testing that Quintiles did when validating its laboratory developed tests, and the individual standard operating procedures used during this process.

Alan Stall, BD Fellow, Principal Scientist for R&D at BD Biosciences, will also be presenting during this webinar.

Register for Event


Mark Edinger
Flow Cytometry

Mark Edinger is the scientific advisor for Flow Cytometry at Q2 Solutions. As the scientific advisor, Mark is responsible for flow cytometry assay design and implementation. He works with both the Translational Biomarkers Laboratory to develop assays and the Global Cytometry Group to produce assays, and is the architect of the systems and workflows used in Q2 Solutions’ flow cytometry assay development and production laboratories.

Mark began his career at the Cleveland Clinic Foundation, a preeminent medical institution, where he pioneered flow cytometry in the late 1970s, building both clinical and research core flow cytometry laboratories. During his 21 years at the Cleveland Clinic, Mark developed many of the techniques and assays employed today for clinical practice and academic research. During this time, Mark also was a consultant for Becton Dickinson (BD) Immunocytometry Systems and participated in clinical trials of new BD products. In 1998, Mark formally joined BD where he founded the Technical Applications Group, and later the R&D Systems Validation Laboratory. While at BD, Mark, working with scientists at Amgen, developed the whole blood phosphoprotein lysing buffer that is now used daily in laboratories throughout the world. Mark joined Quintiles in 2012 and has been part of a collaboration which introduced the quantitative standardization of flow cytometers, along with other state of the art practices, making Quintiles flow laboratories the first to offer this level of instrument standardization anywhere in the world. Mark became part of the Q2 Solutions team when the company was officially launched in June 2015 as a result of a Quintiles and Quest Diagnostics joint venture.

Mark graduated from Case Western Reserve University with a Bachelor of Science degree in Biology.